Management of patients with a calcified aorta or low ejection fraction undergoing multivessel coronary

W Brent Keeling1, Michael E Halkos, John D Puskas

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.

Insights

Off-pump coronary artery bypass surgery (OPCAB) offers a safer alternative for patients with calcified aortas or left ventricular dysfunction. This technique avoids cardiopulmonary bypass and aortic manipulation, reducing risks during coronary revascularization.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Techniques

Background:

  • Off-pump coronary artery bypass (OPCAB) surgery is an alternative to traditional bypass grafting.
  • Coronary artery bypass grafting is a common procedure for treating coronary artery disease.

Purpose of the Study:

  • To highlight the benefits of OPCAB in specific patient populations.
  • To emphasize OPCAB as a viable option for patients with a calcified aorta.
  • To present OPCAB as a suitable revascularization method for patients with left ventricular dysfunction.

Main Methods:

  • Coronary anastomoses are constructed without cardiopulmonary bypass.
  • Aortic manipulation, including cannulation and clamping, is avoided.
  • Myocardial ischemia associated with cardioplegic arrest is prevented.

Main Results:

  • OPCAB allows for safe construction of distal and proximal anastomoses in patients with a calcified aorta.
  • Revascularization is achieved without global myocardial ischemia in patients with left ventricular dysfunction.
  • OPCAB provides an alternative surgical revascularization method.

Conclusions:

  • OPCAB is indicated for patients with a calcified aorta.
  • OPCAB is a beneficial technique for patients with left ventricular dysfunction.
  • OPCAB offers advantages over traditional methods in specific patient groups.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...